Absent Unusual Circumstances, Column IV Costs Remain the Standard in PM(NOC) Proceedings22 Oct 2015Jonathan GiraldiJustice O’Reilly’s decision in Novartis Pharmaceuticals Canada Inc. v. Teva Canada Limited confirms that costs awarded at the upper end of Column...Read More